Literature DB >> 7468481

Treatment of d-transposition of the great arteries: management of hypoxemia after balloon atrial septostomy.

C G Henry, D Goldring, A F Hartmann, C S Weldon, A W Strauss.   

Abstract

Between 1975 and 1979, a group of 43 patients with d-transposition of the great arteries were diagnosed and underwent Rashkind balloon atrial septostomy at the time of initial catheterization. Thirty-six (88 percent) survived to the time of intraatrial baffle repair, and 31 (72 percent) are long-term survivors, 2 of them now awaiting repair. Palliative operations were performed in nine patients before definitive surgery; four of these patients are long-term survivors. Prostaglandin E1 infusion improved oxygenation and relieved acidosis in four patients. It is concluded that most patients with d-transposition of the great arteries will survive to elective intraatrial baffle repair between 6 and 12 months without surgical palliation in spite of significant hypoxemia. Prostaglandin E1 infusion may be lifesaving and provide sufficient palliation in patients with persistent hypoxemia and acidosis after balloon atrial septostomy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7468481     DOI: 10.1016/0002-9149(81)90401-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Balloon atrial septostomy via the umbilical vein.

Authors:  E G Abinader
Journal:  Br Heart J       Date:  1992-02

2.  Fate of infants with transposition of the great arteries in relation to balloon atrial septostomy.

Authors:  T G Powell; M Dewey; C R West; R Arnold
Journal:  Br Heart J       Date:  1984-04

Review 3.  The pharmacological treatment of patent ductus arteriosus. A review of the evidence.

Authors:  R J Barst; W M Gersony
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

4.  Use of prostaglandin E2 in management of transposition of great arteries before balloon atrial septostomy.

Authors:  A Beitzke; C H Suppan
Journal:  Br Heart J       Date:  1983-04

5.  Prostaglandin E2 administration in infants with ductus-dependent cyanotic congenital heart disease.

Authors:  B D Thanopoulos; A Andreou; C Frimas
Journal:  Eur J Pediatr       Date:  1987-05       Impact factor: 3.183

6.  Prostaglandin E2 after septostomy for simple transposition.

Authors:  Lynne Mary Beattie; Karen A McLeod
Journal:  Pediatr Cardiol       Date:  2008-12-16       Impact factor: 1.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.